The goal of the research, Mobarak explains, was to establish a clearer understanding of global vaccination attitudes by using a large and diverse sample of countries. The authors include scholars from Innovations for Poverty Actions, the International Growth Center, the Yale Research Initiative on Innovation and Scale, WZB Berlin Social Science Center, and other institutions in countries around the world. Respondents were asked about their willingness to take the COVID-19 vaccine when available, as well as their motivations for taking it, concerns about it, and most trusted source of vaccine information. The research drew on phone surveys of more than 44,000 people in the United States, Russia, and 10 low- and middle-income countries (LMICs) across Asia, Africa, and South America, administered between June 2020 and January 2021. Willingness to get the COVID-19 vaccine is significantly higher in low- and middle-income countries (LMICs) than in the United States or Russia, according to the study on global COVID-19 vaccine acceptance and hesitancy, whose co-authors include Mushfiq Mobarak of Yale SOM and Saad Omer, director of the Yale Institute for Global Health. But according to a new study, once more vaccines are made available in the developing world, there will be plenty of people eager to receive them-a finding that underscores the importance of global vaccine equity in saving lives and preventing the evolution of new, more dangerous variants. Meanwhile, public health experts are raising the alarm that the highly contagious Delta variant is spreading through unvaccinated populations-and additional variants could arise as long as the disease is endemic. In the United States, where COVID-19 vaccines are plentiful, the biggest remaining obstacle to protecting the population is vaccine hesitancy.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |